Form 8-K CLOVER HEALTH INVESTMENT For: Feb 23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Clover Health Investments (CLOV) Q4 Revenue Tops Consensus
February 23, 2022 4:24 PM ESTClover Health Investments (NASDAQ: CLOV) reported Q4 revenue of $432 million versus the consensus estimate of $408.14 million.
GUIDANCE:
Clover Health Investments sees FY2022 revenue of $3-3.4 billion, versus the consensus of $2.62 billion. Total revenues are expected to be in the... More